Aandeel TXTM PROTEXT MOBILITY, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen ProText Mobility, Inc. Other OTC

Aandelen

TXTM

US74371E2046

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
PROTEXT MOBILITY, INC. (TXTM) ADDRESSES ALLEGED PROMOTIONAL ACTIVITY AND OTC MARKETS CE DESIGNATION
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE
Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update
RSAMMD ACQUISITIONS LLC AND PROTEXT MOBILITY, INC. (TXTM) PROVIDE SHAREHOLDERS UPDATE AND NEAR TERM ROAD MAP
ProText Mobility : Quarterly Report - Protext Q3 2021 - Amended
ProText Mobility : Quarterly Report
ProText Mobility : Notification of Late Filing
PROTEXT MOBILITY ANNOUCNES SIGNING OF LETTER OF INTENT TO ACQUIRE PREMIER VODKA BRAND
ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Announces Successful Testing Results of Proprietary Cannabis Plant Extraction Technology with JV Partner Protex Pharma (TXTM)
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Signs Letter of Intent with USA-based Protext Pharma (TXTM) for Commercialization of Next Generation Live Cannabis and Hemp Extraction Technology
ProText Mobility, Inc. cancelled the acquisition of 60% in Growprocess, Inc.
Protext Pharma to Acquire Cannabis Blockchain Company Growprocess, Inc.
ProText Mobility, Inc. signed a letter of intent to acquire 60% in Growprocess, Inc.
Protext Pharma : Announces South Africa's Reclassification of Cannabis as a Schedule 4 Substance
Protext Pharma : to Conduct Clinical Trial to Determine Therapeutic Dosage Levels for Treating Diabetes
Protext Mobility : Completes Name Change to Protext Pharma and Provides Update on Medical Cannabis License
ProText Mobility, Inc. has Changed its Name to Protext Pharma, Inc
Protext Mobility : Signs Agreement With Leading Research Center, CIDP, to Conduct Diabetes Human Clinical Trial
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers TXTM
  4. Koers TXTM
  5. Nieuws ProText Mobility, Inc.
  6. Andere talen